This appeared in print version of NYT on Monday.
Post# of 22456
Chile will issue ‘immunity cards’ to people who have recovered from the virus.
Chile is set to become the first country to issue “immunity cards” to those who have recovered from the coronavirus, allowing holders to return to work, despite questions about whether those who have recovered are in fact immune, how long any immunity might last, and the accuracy of antibody tests.
“We have to learn to live differently,” Dr. Paula Daza, the undersecretary in Chile’s health ministry, said on Sunday, adding that Chileans must “gradually resume our lives.”
Anyone can apply for the cards, which will be issued starting Monday. To qualify, Chileans have to take a test that shows they have antibodies for the novel coronavirus. Those who have had the disease must be free of symptoms for at least 14 days — or 28, if they have a compromised immune system.
Under those criteria, 4,338 people are eligible, Dr. Daza said.
But critics have questioned the notion that recovered patients are not contagious and immune to re-infection, and raised doubts about the tests’ accuracy.
Chile has imposed quarantines that remain in place across parts of the capital, Santiago, and in other regions of the country. It has also tested more people for the virus than any other Latin American country, identifying 10,088 coronavirus cases, and 133 deaths.
The health minister, Jaime Mañalich, has reiterated that “the worst is yet to come,” with the number of cases expected to peak in May. The flu season, which is fast approaching along with winter in the southern hemisphere, is likely to strain Chile’s public health system further.
Nonetheless, the government has announced that public sector employees will also return to their offices starting Monday.
“The message coming from the government is contradictory,” said Dr. Jorge Jiménez de la Jara, who served as Chile’s health minister upon the country’s return to democracy in 1990.
“We don’t know what is going to happen from here, but there certainly needs to be clearer, more coherent communication, because this latest decision to certify immunity is based on weak scientific evidence,” he said.